|4Feb 21, 4:15 PM ET

Jallal Bahija 4

4 · Immunocore Holdings plc · Filed Feb 21, 2024

Insider Transaction Report

Form 4
Period: 2024-02-16
Jallal Bahija
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Employee Share Option (Right to Buy)

    2024-02-16+281,819281,819 total
    Exercise: $70.50Exp: 2034-02-15Ordinary Shares (281,819 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    form4-02212024_040209.xmlPrimary